Cancers 2012, 4(4), 1067-1105; doi:10.3390/cancers4041067
Review

High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals

1 Department of Chemistry and Biochemistry, Concordia University, Montreal H4B 1R6, Canada 2 Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid 28049, Spain 3 Departamento de Fisiología. Facultad de Medicina, Universidad Autónoma de Madrid, Madrid 28029, Spain 4 Institut National de la Recherche Scientifique-Énergie, Matériaux et Télécommunications, Université du Québec, Varennes J3X 1S2, Canada 5 Departamento de Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
* Authors to whom correspondence should be addressed.
Received: 13 August 2012; in revised form: 20 September 2012 / Accepted: 15 October 2012 / Published: 22 October 2012
(This article belongs to the Special Issue Nanotechnology and Cancer Therapeutics)
PDF Full-text Download PDF Full-Text [2057 KB, uploaded 22 October 2012 14:37 CEST]
Abstract: During the last decade inorganic luminescent nanoparticles that emit visible light under near infrared (NIR) excitation (in the biological window) have played a relevant role for high resolution imaging of cancer. Indeed, semiconductor quantum dots (QDs) and metal nanoparticles, mostly gold nanorods (GNRs), are already commercially available for this purpose. In this work we review the role which is being played by a relatively new class of nanoparticles, based on lanthanide ion doped nanocrystals, to target and image cancer cells using upconversion fluorescence microscopy. These nanoparticles are insulating nanocrystals that are usually doped with small percentages of two different rare earth (lanthanide) ions: The excited donor ions (usually Yb3+ ion) that absorb the NIR excitation and the acceptor ions (usually Er3+, Ho3+ or Tm3+), that are responsible for the emitted visible (or also near infrared) radiation. The higher conversion efficiency of these nanoparticles in respect to those based on QDs and GNRs, as well as the almost independent excitation/emission properties from the particle size, make them particularly promising for fluorescence imaging. The different approaches of these novel nanoparticles devoted to "in vitro" and "in vivo" cancer imaging, selective targeting and treatment are examined in this review.
Keywords: cancer; fluorescence imaging; lanthanide-doped nanocrystals; upconversion; targeting

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Naccache, R.; Rodríguez, E.M.; Bogdan, N.; Sanz-Rodríguez, F.; Cruz, M.C.I.; Fuente, Á.J.; Vetrone, F.; Jaque, D.; Solé, J.G.; Capobianco, J.A. High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals. Cancers 2012, 4, 1067-1105.

AMA Style

Naccache R, Rodríguez EM, Bogdan N, Sanz-Rodríguez F, Cruz MCI, Fuente ÁJ, Vetrone F, Jaque D, Solé JG, Capobianco JA. High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals. Cancers. 2012; 4(4):1067-1105.

Chicago/Turabian Style

Naccache, Rafik; Rodríguez, Emma Martín; Bogdan, Nicoleta; Sanz-Rodríguez, Francisco; Cruz, Maria del Carmen Iglesias de la; Fuente, Ángeles Juarranz de la; Vetrone, Fiorenzo; Jaque, Daniel; Solé, José García; Capobianco, John A. 2012. "High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals." Cancers 4, no. 4: 1067-1105.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert